CREO — Creo Medical Share News
0.000.00%
Last trade - 00:00- £61.20m
- £52.90m
- £6.00m
Director/PDMR Share Dealing
Speedboat® patient testimonial
Award of Shares under SIP and Director Dealings
Brief: Creo Medical Says Tracking On Plan For 40% To 60% Revenue Growth For FY
H1’25 Trading Update
MicroBlate™ Flex begins lung tumour clinical study
PDMR Options Revision
AGM Statement and Directorate Changes
Brief: Creo Medical Group Announces U.S. FDA Clearance For SpydrBlade™ Flex
U.S. FDA clearance for SpydrBlade™ Flex
Director/PDMR Shareholding
Posting of AR&R and Notice of AGM
Holding(s) in Company
Holding(s) in Company
Directorate changes
Brief: Creo Medical Group Announces FY24 Results In Line With Expectations
Final Results
Notice of Results
Holding(s) in Company